<?xml version="1.0" encoding="UTF-8"?>
<ref id="B53">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Twardowski</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Kanaya</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Frankel</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Synold</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Ruel</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Pal</surname>
    <given-names>S. K.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2015</year>). 
  <article-title>A phase I trial of mushroom powder in patients with biochemically recurrent prostate cancer: roles of cytokines and myeloid-derived suppressor cells for Agaricus bisporus-induced prostate-specific antigen responses</article-title>. 
  <source>Cancer</source>
  <volume>121</volume>, 
  <fpage>2942</fpage>â€“
  <lpage>2950</lpage>. 
  <pub-id pub-id-type="doi">10.1002/cncr.29421</pub-id>
  <pub-id pub-id-type="pmid">25989179</pub-id>
 </mixed-citation>
</ref>
